PAM
ALXN

Premier Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Premier Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-68,350
Closed -$7.67M – 180
2020
Q2 		$7.67M Buy
+68,350
New +$7.26M 2.56% 14
2019
Q4 		– Sell
-80,515
Closed -$7.89M – 138
2019
Q3 		$7.89M Sell
80,515
-7,695
-9% -$867K 1.88% 26
2019
Q2 		$11.6M Sell
88,210
-1,575
-2% -$203K 2.72% 17
2019
Q1 		$12.1M Buy
89,785
+73,860
+464% +$9.18M 2.89% 10
2018
Q4 		$1.55M Sell
15,925
-72,070
-82% -$8.52M 0.42% 43
2018
Q3 		$12.2M Sell
87,995
-1,580
-2% -$198K 2.73% 15
2018
Q2 		$11.1M Buy
89,575
+69,925
+356% +$8.17M 2.62% 18
2018
Q1 		$2.19M Buy
19,650
+9,145
+87% +$1.09M 0.49% 38
2017
Q4 		$1.26M Sell
10,505
-44,035
-81% -$5.36M 0.28% 57
2017
Q3 		$7.65M Buy
+54,540
New +$7.41M 1.72% 30
2016
Q4 		– Sell
-81,085
Closed -$9.94M – 110
2016
Q3 		$9.94M Sell
81,085
-3,335
-4% -$429K 2.47% 21
2016
Q2 		$9.86M Buy
84,420
+14,155
+20% +$2.01M 2.54% 20
2016
Q1 		$9.78M Buy
70,265
+360
+0.5% +$52.9K 2.52% 21
2015
Q4 		$13.3M Sell
69,905
-1,345
-2% -$235K 3.32% 12
2015
Q3 		$11.1M Buy
71,250
+405
+0.6% +$73.9K 2.82% 17
2015
Q2 		$12.8M Buy
70,845
+385
+0.5% +$66.4K 3.02% 15
2015
Q1 		$12.2M Buy
70,460
+1,710
+2% +$310K 2.83% 18
2014
Q4 		$12.7M Buy
68,750
+560
+0.8% +$104K 3.11% 14
2014
Q3 		$11.3M Buy
+68,190
New +$11.2M 2.89% 16

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Premier Asset Management's ALXN Position: Q3 2020 in Review

Premier Asset Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2020, closing a stake of 68,350 shares — an estimated $7.67M sold.

Premier Asset Management first reported a position in ALXN in Q3 2014 and held it in 19 quarters. The position peaked at $13.3M in Q4 2015. 709 funds tracked by Wall St. Rank hold ALXN as of Q3 2020.

  • Premier Asset Management reported no remaining Alexion Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Premier Asset Management sold 68,350 Alexion Pharmaceuticals shares in Q3 2020, an estimated $7.67M.
  • Premier Asset Management first reported a position in Alexion Pharmaceuticals in Q3 2014 and held it in 19 quarters.
  • Premier Asset Management's Alexion Pharmaceuticals position peaked at $13.3M in Q4 2015.
  • 709 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2020.

Based on Premier Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.